ORIGINAL ARTICLE

Short term effects of adrenaline in bronchiolitis: a randomised controlled trial

A Abul-Ainine, D Luyt

Children's Hospital, Leicester Royal Infirmary, University Hospitals of Leicester, Leicester, UK

Correspondence to:
Correspondence to:
Dr D Luyt, Children's Intensive Care Unit, Leicester Royal Infirmary, Leicester LE1 5WW, UK;
david.luyt{at}btinternet.com

Background: Airway narrowing in acute bronchiolitis does not respond to inhaled bronchodilators but does to adrenaline when compared to bronchodilators. Influences of supportive care were not considered in previous treatment studies.

Methods: Short term effects of nebulised adrenaline and saline placebo were compared in infants with moderately severe acute bronchiolitis. Thirty eight infants were recruited, 19 in each treatment group. After stabilisation, infants received a single 3 ml dose of either levo-adrenaline (3 mg) or 0.9% saline placebo via Pari-BABY nebuliser driven with 6 l/min oxygen for three minutes. Changes in respiratory rate (RR), heart rate (HR), oxygen saturation (SpO₂), Respiratory Distress Assessment Instrument (RDAI), and activity levels were assessed at 20 minutes intervals at times -20, 0, 20, 40, and 60 minutes around treatment. Respiratory virology and chest x ray were performed.

Results: Supportive therapy prior to study treatment resulted in significant reductions in RR (by 4.3 breaths/min) and HR (by 4.6 beats/min); there were no changes in SpO₂ or RDAI. There were no further changes in any parameter in either treatment group at any assessment time after treatment.

Conclusion: No improvement was shown with inhaled adrenaline in acute bronchiolitis, when compared with supportive care or placebo. Improvements noted pretreatment question whether prior noted improvements were through supportive care or pharmacological interventions.

Keywords: acute bronchiolitis; nebulised; epinephrine; adrenaline; bronchodilator; wheezy infant

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Gotzsche, P. C., Hrobjartsson, A., Maric, K., Tendal, B. (2007). Data Extraction Errors in Meta-analyses That Use Standardized Mean Differences. JAMA 298: 430-437 [Abstract] [Full Text]  
• Meates-Dennis, M. (2005). BRONCHIOLITIS. EDUCATION AND PRACTICE 90: ep81-ep86 [Full Text]  
• Mull, C. C., Scarfone, R. J. (2004). Bronchiolitis--Reply. Arch Pediatr Adolesc Med 158: 707-708 [Full Text]  
• Barbi, E., Neri, E., Ventura, A. (2004). Nomina Sunt Consequentia Rerum: Time for a Change in the Definition of Bronchiolitis?. Arch Pediatr Adolesc Med 158: 403-403 [Full Text]  
• Mull, C. C., Scarfone, R. J., Ferri, L. R., Carlin, T., Salvaggio, C., Bechtel, K. A., Trephan, M. A. H., Rissman, R. L., Gracely, E. J. (2004). A Randomized Trial of Nebulized Epinephrine vs Albuterol in the Emergency Department Treatment of Bronchiolitis. Arch Pediatr Adolesc Med 158: 113-118 [Abstract] [Full Text]  
• (2003). Minerva. BMJ 327: E121-121 [Full Text]  
• Hartling, L., Wiebe, N., Russell, K., Patel, H., Klassen, T. P. (2003). A Meta-analysis of Randomized Controlled Trials Evaluating the Efficacy of Epinephrine for the Treatment of Acute Viral Bronchiolitis. Arch Pediatr Adolesc Med 157: 957-964 [Abstract] [Full Text]  
• (2003). OTHER ARTICLES NOTED (Nov 01 to 18 Oct 02). Evid. Based Nurs. 6: e1-1 [Full Text]  
• Meates, M. (2002). Does nebulised adrenaline (epinephrine) reduce admission rate in bronchiolitis?. Arch. Dis. Child. 87: 548-550 [Full Text]  
• Wyatt, J., Bellis, F. (2002). JournalScan. Emerg. Med. J. 19: 435-436 [Full Text]